A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 Via an Implantable Pump and a Cranial Port and Double Lumen Catheter (ICVRX) in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
Latest Information Update: 18 Mar 2024
At a glance
- Drugs Valproic acid (Primary)
- Indications Epilepsy; Partial epilepsies; Seizures
- Focus Therapeutic Use
- Sponsors Cerebral Therapeutics
Most Recent Events
- 11 Mar 2024 Status changed from recruiting to discontinued.
- 07 Feb 2023 Planned End Date changed from 1 Sep 2022 to 1 Jul 2024.
- 07 Feb 2023 Planned primary completion date changed from 1 Jul 2022 to 1 Jul 2024.